Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Clinical Evaluation of the OncAlert RAPID; Impact on Decision-Making

NCT03239834 is registered in ClinicalTrials.gov with Vigilant Biosciences, Inc. as lead sponsor.

NCT NCT03239834
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03239834 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Clinical Evaluation of the OncAlert RAPID; Impact on Decision-Making
Lead sponsor
Vigilant Biosciences, Inc.
Phase
Observational
Overall status
Completed
Start date
September 7, 2017
Completion date
December 20, 2020
Enrollment
893 (actual)
Sites
26

Conditions

As the registry lists them; a condition with its own page is linked.

gingival neoplasms, leukoplakia, oral, lip neoplasm, oral ulcer, oropharyngeal neoplasms, palatal neoplasms, tongue neoplasms